Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease
Wei Jiang,Chun Gan,Xindi Zhou,Qing Yang,Dan Chen,Han Xiao,Lujun Dai,Yaxi Chen,Mo Wang,Haiping Yang,Qiu Li
DOI: https://doi.org/10.1186/s12933-023-02025-w
IF: 8.949
2023-10-29
Cardiovascular Diabetology
Abstract:Diabetic kidney disease (DKD) is characterized by the abnormal deposition of oxidized low-density lipoprotein (ox-LDL), which contributes to podocyte damage. Klotho, an aging suppressor that plays a critical role in protecting podocytes in DKD, is mainly expressed in kidney tubular epithelium and secreted in the blood. However, it has not been established whether Klotho can alleviate podocyte injury by inhibiting renal ox-LDL deposition, and the potential molecular mechanisms require further investigation.
cardiac & cardiovascular systems,endocrinology & metabolism
What problem does this paper attempt to address?